Kimberly E. Vanover Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kimberly E. Vanover.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kimberly E. Vanover. Kimberly E. Vanover is SVP, Clinical Development in Intra-Cellular Therapies, Inc. ($ITCI) and SVP, Early Stage Clinical Dev. in Intra-Cellular Therapies, Inc. ($ITCI) and VP, Clinical Development in Intra-Cellular Therapies, Inc. ($ITCI).
Latest Insider Trading Transactions of Kimberly E. Vanover
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 1,554 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 1,554 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 12.29 | 592 | 7,276 | 27,068 | 27.7 K to 27.1 K (-2.14 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 12.29 | 592 | 7,276 | 27,068 | 27.7 K to 27.1 K (-2.14 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.81 | 2,184 | 25,793 | 27,660 | 29.8 K to 27.7 K (-7.32 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.81 | 2,184 | 25,793 | 27,660 | 29.8 K to 27.7 K (-7.32 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.37 | 7,380 | 83,911 | 29,844 | 37.2 K to 29.8 K (-19.83 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.37 | 7,380 | 83,911 | 29,844 | 37.2 K to 29.8 K (-19.83 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 1,554 | 0 | 37,224 | 35.7 K to 37.2 K (+4.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 1,554 | 0 | 37,224 | 35.7 K to 37.2 K (+4.36 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 2,649 | 0 | 2,649 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 16,160 | 0 | 35,670 | 19.5 K to 35.7 K (+82.83 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 2,649 | 0 | 19,510 | 16.9 K to 19.5 K (+15.71 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.10 | 4,834 | 53,657 | 16,861 | 21.7 K to 16.9 K (-22.28 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Grant | A | 0.00 | 9,322 | 0 | 21,695 | 12.4 K to 21.7 K (+75.34 %) |
| Jan 10 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 17.46 | 772 | 13,479 | 12,373 | 13.1 K to 12.4 K (-5.87 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,554 | 0 | 1,554 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 2,648 | 0 | 5,298 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 17.37 | 1,185 | 20,583 | 13,145 | 14.3 K to 13.1 K (-8.27 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,554 | 0 | 14,330 | 12.8 K to 14.3 K (+12.16 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 2,648 | 0 | 12,776 | 10.1 K to 12.8 K (+26.15 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 16.59 | 800 | 13,272 | 10,128 | 10.9 K to 10.1 K (-7.32 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,553 | 0 | 3,108 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 7,946 | 0 | 7,946 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 15.73 | 31,858 | 501,126 | 31,858 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,553 | 0 | 10,928 | 9.4 K to 10.9 K (+16.57 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.50 | 3,750 | 5,625 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.50 | 10,000 | 15,000 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.36 | 5,000 | 6,800 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.28 | 1,875 | 28,644 | 9,375 | 11.3 K to 9.4 K (-16.67 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.50 | 3,750 | 5,625 | 11,250 | 7.5 K to 11.3 K (+50.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.19 | 5,000 | 75,973 | 7,500 | 12.5 K to 7.5 K (-40.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.50 | 10,000 | 15,000 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.26 | 2,500 | 38,156 | 2,500 | 5 K to 2.5 K (-50.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.36 | 5,000 | 6,800 | 5,000 | 0 to 5 K |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 0.00 | 4,661 | 0 | 4,661 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 53.63 | 19,653 | 1,053,990 | 19,653 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 17.57 | 72,120 | 1,267,148 | 72,120 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 16.86 | 100,000 | 1,686,000 | 100,000 |
Page: 1